Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter

DOI: 10.1177/1756287218815372

Keywords: antiangiogenic agents, chemotherapy, gene expression profiling, immunotherapy, target therapies, upper urinary tract, urothelial carcinoma

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text